Alejandro said researchers are exploring another potential use for GLP-1 agonists: preserving or even increasing the number of insulin-producing islet cells in the pancreas
Why GLP-1s May Undermine Long-Term Results GLP-1 medications were originally designed to help regulate blood sugar in diabetics, but they are now widely used for weight loss
Viking Therapeutics: In November, Viking Therapeutics reported that in a small phase 1 clinical study, patients who took a daily 100mg dose of Vikings weight-loss pill lost an average of up to 6.8% of their body weight over 28 days when adjusted for those taking a placebo
Three medications are currently FDA-approved for treating alcohol use disorder: naltrexone (reduces cravings and blocks alcohol's pleasurable effects), acamprosate (helps maintain abstinence), and disulfiram (causes unpleasant reactions when alcohol is consumed)
Activated microglia release nitric oxide and other mediators that, when combined with superoxide, form peroxynitrite, a highly reactive species capable of damaging proteins, lipids, and DNA
3.2.6 Mitochondrial transplantation (cell-based biologic therapy) A groundbreaking new approach is direct mitochondrial transplantation (MTx)